— Know what they know.
Not Investment Advice
Also trades as: 0QNA.L (LSE) · $vol 1M · BPMUF (OTC) · $vol 0M

BSLN.SW SIX

Basilea Pharmaceutica AG
1W: -2.8% 1M: +1.8% 3M: +24.6% YTD: +14.2% 1Y: +43.0% 3Y: +41.7% 5Y: +40.5%
CHF 66.80 ($80.63)
-1.00 (-1.47%)
 
Weekly Expected Move ±4.6%
CHF 61 CHF 64 CHF 67 CHF 70 CHF 73
SIX · Healthcare · Biotechnology · Tech Score Buy · Power 57 · CHF 826.8M mcap · 12M float · 0.314% daily turnover

📊 Key Metrics

TTM
CHF 432M
Revenue
+33.6% YoY
CHF 117M
Net Income
+110.8% YoY
CHF 122M
Free Cash Flow
+233.0% YoY
87.0%
Gross Margin
26.5%
Op. Margin
23.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE130.7%
ROA48.1%
ROIC170.3%

Valuation

P/E15.7
P/B5.1
EV/EBITDA5.0

Leverage

Debt/Equity0.51
Current Ratio6.60
Interest Cov.18.7x

Quality Scores

Piotroski F8/9
Altman Z3.00
Beneish M-1.62

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms